title: Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source.
abstract: A variety of adult stem cells have been used to transplant into the infarcted (MI) heart, however, comparative studies are lacking to show more suitable source of cells for transplantation. We have identified a single non-hematopoietic mesenchymal stem cell subpopulation (snMSCs) isolated from human bone marrow and clonally purified, that over 99% of them expressed MSC marker proteins and cardiomyocyte marker proteins when induction in vitro. We also compared the effects of the snMSCs with unpurified MSC (uMSCs), mononuclear cells (BMMNCs), or peripheral blood mononuclear cells (PBMNCs) on myocardial repair after induction of MI in rats. Ninety days later, we observed a better cardiac function assessed by ejection fraction, fraction of shortening and lung wet/dry weight ratios, less remodeling of left ventricle (LV), lower collagen density in the LV, and more vessels in the ischemic wall in the snMSCs transplantation group than in other cell-transplanted groups. Furthermore, the transplanted cells expressing cardiomyocyte specific proteins or vascular endothelial cell marker proteins were more in the snMSCs group than in other ones. We conclude that transplantation with single clonally purified MSCs seems to be more beneficial to the cardiac repair than with other stem cells after MI.
authors.affiliation: Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
authors.forename: Shaoheng
authors.initials: S
authors.lastname: Zhang
authors.forename: Junbo
authors.initials: J
authors.lastname: Ge
authors.forename: Aijun
authors.initials: A
authors.lastname: Sun
authors.forename: Danling
authors.initials: D
authors.lastname: Xu
authors.forename: Juying
authors.initials: J
authors.lastname: Qian
authors.forename: Jinyi
authors.initials: J
authors.lastname: Lin
authors.forename: Yan
authors.initials: Y
authors.lastname: Zhao
authors.forename: Haifeng
authors.initials: H
authors.lastname: Hu
authors.forename: Ying
authors.initials: Y
authors.lastname: Li
authors.forename: Keqiang
authors.initials: K
authors.lastname: Wang
authors.forename: Yunzeng
authors.initials: Y
authors.lastname: Zou
mesh_terms: D000328:Adult; D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology*; D002452:Cell Count; D002454:Cell Differentiation; D064987:Cell- and Tissue-Based Therapy; D002999:Clone Cells; D003094:Collagen / Q000378:metabolism; D004195:Disease Models, Animal; D006321:Heart / Q000503:physiopathology; D006413:Hematopoietic System / Q000166:cytology*; D006801:Humans; D007249:Inflammation; D007963:Leukocytes, Mononuclear / Q000166:cytology; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy*; D032383:Myocytes, Cardiac / Q000166:cytology; D009389:Neovascularization, Pathologic; D018919:Neovascularization, Physiologic; D009929:Organ Size; D051381:Rats; D017207:Rats, Sprague-Dawley; D014945:Wound Healing
chemical_list: D003094:Collagen